The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma.

The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma.

Blog Article

C-reactive protein (CRP) has previously been shown to serve as a prognostic parameter in women with gynecologic malignancies.Due to the lack of valid prognostic markers for uterine leiomyosarcoma (ULMS) this study set iphone 14 price montreal out to investigate the value of pre-treatment CRP serum levels as prognostic parameter.Data of women with ULMS were extracted from databases of three Austrian centres for gynaecologic oncology.Pre-treatment CRP serum levels were measured and correlated with clinico-pathological parameters.

Univariate and multivariable survival analyses were performed.In total, 53 patients with ULMS were included into the analysis.Mean (SD) CRP serum level was 3.46 mg/dL (3.

96).Solely, an association between pre-treatment CRP serum levels and tumor size (p = 0.04) but no other clinic-pathologic parameter such as tumor stage (p = 0.16), or histological grade (p = 0.

07), was observed.Univariate and multivariable survival analyses revealed that CRP serum levels (HR 2.7 [1.1-7.

2], p = 0.037) and tumor stage (HR 6.1 [1.9-19.

5], p = 0.002) were the only independent prognostic factors for overall survival (OS) in patients with ULMS.Patients with high pre-treatment CRP serum levels showed impaired OS compared to women with low levels samsung ue43au7105kxxc (5-year-OS rates: 22.6% and 52.

3%, p = 0.007).High pre-treatment CRP serum levels were independently associated with impaired prognosis in women with ULMS and might serve as a prognostic parameter in these patients.